Ángela Naranjo

Ms. Ángela Naranjo

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2022 in Journal of Catalysis
Verified
Journal Article
Open access
CMCarlos Moreno-Castilla
Carlos Moreno-Castilla
ÁNÁngela Naranjo
Ángela Naranjo
Maria Victoria RamonMaria Victoria Ramon
Maria Victoria Ramon
ESEva Siles
Eva Siles
JLJesús J. López-Peñalver
Jesús J. López-Peñalver
JAJosé Mariano Ruiz de Almodóvar
José Mariano Ruiz de Almodóvar

Verified
Journal Article
Open access
PDF file
ÁNÁngela Naranjo
Ángela Naranjo
MÁM. Josefa Álvarez-Soria
M. Josefa Álvarez-Soria
PAPilar Aranda-Villalobos
Pilar Aranda-Villalobos
AMAna María Martínez-Rodríguez
Ana María Martínez-Rodríguez
EMEsther Martínez-Lara
Esther Martínez-Lara
ESEva Siles
Eva Siles
Hydroxytyrosol (HT) is a bioactive olive oil phenol with beneficial effects in a number of pathological situations. We have previously demonstrated that an HT-enriched diet could serve as a beneficial therapeutic approach to attenuate ischemic-stroke-associated damage in mice. Our exploratory pilot study examined this effect in humans. Particularly, a nutritional supplement containing 15 mg of HT/day was administered to patients 24 h after the onset of stroke, for 45 days. Biochemical and oxidative-stress-related parameters, blood pressure levels, serum proteome, and neurological and functional outcomes were evaluated at 45 and 90 days and compared to a control group. The main findings were that the daily administration of HT after stroke could: (i) favor the decrease in the percentage of glycated hemoglobin and diastolic blood pressure, (ii) control the increase in nitric oxide and exert a plausible protective effect in oxidative stress, (iii) modulate the evolution of the serum proteome and, particularly, the expression of apolipoproteins, and (iv) be beneficial for certain neurological and functional outcomes. Although a larger trial is necessary, this study suggests that HT could be a beneficial nutritional complement in the management of human stroke.

1 July 2023 in Journal of Medicinal Food
Verified
Journal Article
Closed access
JCJesús Calahorra
Jesús Calahorra
SASalomé Araujo-Abad
Salomé Araujo-Abad
JGJosé M. Granadino-Roldán
José M. Granadino-Roldán
ÁNÁngela Naranjo
Ángela Naranjo
EMEsther Martínez-Lara
Esther Martínez-Lara
ESEva Siles
Eva Siles
In solid tumors, such as breast cancer, hypoxic microenvironment worsens patient prognoses. We have previously reported in MCF-7 breast cancer cells that, under hypoxic conditions, hydroxytyrosol (HT) downregulates the level of reactive oxygen species, reduces the expression of hypoxia inducible factor-1α (HIF-1α), and, at high concentrations, can bind to the aryl hydrocarbon receptor (AhR). With this background, the present study investigated whether the most abundant extra virgin olive oil (EVOO) phenolic compound tyrosol (TYR), with a chemical structure similar to HT but with only one hydroxyl group, exerts comparable effects. Our results revealed that, although TYR did not show any antioxidant activity in hypoxic MCF-7 cells, it inhibited the PI3K/Akt/mTOR/S6 kinase (S6K) pathway and reduced the expression of HIF-1α and some of its target genes. Besides, TYR showed a lower binding affinity with the cytosolic transcription factor AhR, and even reduced its transcriptional activity. Some of these results are positive to control tumor progression in a hypoxic environment; however, they are observed at doses unachievable with diet intake or nutraceutical presentations. Considering that EVOO phenols can have synergistic effects, a mixture of low doses of TYR and other phenols could be useful to achieve these beneficial effects.

8 January 2026 in Cellular and Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
MPMaría Ángeles Peinado
María Ángeles Peinado
Santos BlancoSantos Blanco
Santos Blanco
ÁNÁngela Naranjo
Ángela Naranjo
MMMaría del Mar Muñoz
María del Mar Muñoz
ESEva Siles
Eva Siles
EMEsther Martínez-Lara
Esther Martínez-Lara
Ischemic stroke, a leading cause of disability and mortality, initiates a complex damage cascade within the neurovascular unit (NVU), leading to blood-brain barrier (BBB) disruption and neuroinflammation that severely exacerbates secondary injury. Neuroglobin (Ngb), an endogenous protein induced by brain injury, represents a high-potential neuroprotective target. While the precise mechanisms underlying its protective action remain incompletely elucidated, substantial evidence points to its multifaceted ability to mitigate ischemic damage. To fully unlock this potential, a fundamental understanding of how neurons, astrocytes, microglia, and pericytes, coordinate their function in response to stress, and specifically identifying the role Ngb plays within this integrated cellular network, is required. This review examines the post-stroke interplay among these cells, analyzing current knowledge about how Ngb modulates the collective inflammatory response by suppressing pro-inflammatory pathways and fostering a neuroprotective environment. Furthermore, Ngb’s upregulation in glial cells and pericytes promotes direct neuronal repair mechanisms, such as neurite outgrowth and axonal regeneration, while supporting neuronal survival and BBB integrity. Importantly, evidence suggests that Ngb’s efficacy is most pronounced when its intracellular concentration exceeds the levels achieved through physiological upregulation. In this regard, we integrate broad preclinical evidence with specific insights from nanoparticle-mediated delivery systems that enable effective Ngb transport to NVU cells. These synthesized findings demonstrate beneficial outcomes in stroke models, driven by the modulation of mitochondrial dynamics, cytoskeletal remodeling, and synaptic regeneration pathways. Collectively, the literature indicates that targeted therapeutic Ngb may enhancement strategies effectively complement endogenous levels to orchestrate protective responses across the NVU. Nonetheless, a detailed investigation into the therapeutic utility of Ngb is still required to fully translate encouraging preclinical findings into successful clinical application for improving stroke outcomes. Graphical Abstract

26 March 2026 in Neuroscience Informatics
Verified
Journal Article
Open access
SGSara Gröhn
Sara Gröhn
ÁNÁngela Naranjo
Ángela Naranjo
ONOmar Narvaez
Omar Narvaez
MYMaxime Yon
Maxime Yon
BBBuse Buz-Yalug
Buse Buz-Yalug
ASAlejandra Sierra
Alejandra Sierra